YJP-40102

N/A

Report date: 2023/05/10 20:00:50
NME

Base Information

Drug NameYJP-40102
Drug Alias NameResearch programme: cephalosporin antibacterials - Yungjin Pharm
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsStaphylococcal InfectionsGram-Positive Bacterial InfectionsInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesYungjin PharmaceuticalKorea Institute Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesUtah State University
Inactive CompaniesKorea Institute Of Science And TechnologyYungjin Pharmaceutical
Active IndicationsInfections
Inactive IndicationsStaphylococcal InfectionsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A